Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell P Bowler

Showing results (251-260 of 287) with videos related to

Pageof 29
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 25, 2021
Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical ActivityHeleen Demeyer, Divya Mohan, Chris Burtin, et al.
Chest|June 20, 2014
Prediction of acute respiratory disease in current and former smokers with and without COPDRussell P Bowler, Victor Kim, Elizabeth Regan, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 20, 2015
Comorbidities of COPD have a major impact on clinical outcomes, particularly in African AmericansNirupama Putcha, Meilan K Han, Carlos H Martinez, et al.
Respiratory Research|July 4, 2025
Proteomic discovery analysis of quantitatively assessed emphysema in the general population. The MESA Lung StudyDaniel E Guzman, Lisa Ruvuna, Claire J Guo, et al.
Nature Communications|February 19, 2024
Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R StudyJohn S Kim, Yifei Sun, Pallavi Balte, et al.
NPJ Biofilms and Microbiomes|February 6, 2021
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohortKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 18, 2023
Changes in Lung Volumes with Spirometric Disease Progression in COPDMehrdad Arjomandi, Siyang Zeng, Jianhong Chen, et al.
American Journal of Respiratory and Critical Care Medicine|August 22, 2025
Associations of High Attenuation Area-related Proteomic Biomarkers with Fibrotic or Subpleural Interstitial Lung AbnormalitiesJohn S Kim, Catherine L Debban, Daniel Guzman, et al.
American Journal of Respiratory and Critical Care Medicine|October 7, 2025
Maternal Smoking and CC-16: Implications for Lung Development and COPD Across the LifespanJoselyn Rojas-Quintero, Rosa Faner, Chia-Ying Chiu, et al.
American Journal of Respiratory and Critical Care Medicine|January 23, 2024
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary DiseaseKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
Pageof 29

Showing results (251-260 of 287) with videos related to

Sort By:
Pageof 29
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 25, 2021
Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical ActivityHeleen Demeyer, Divya Mohan, Chris Burtin, et al.
Chest|June 20, 2014
Prediction of acute respiratory disease in current and former smokers with and without COPDRussell P Bowler, Victor Kim, Elizabeth Regan, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 20, 2015
Comorbidities of COPD have a major impact on clinical outcomes, particularly in African AmericansNirupama Putcha, Meilan K Han, Carlos H Martinez, et al.
Respiratory Research|July 4, 2025
Proteomic discovery analysis of quantitatively assessed emphysema in the general population. The MESA Lung StudyDaniel E Guzman, Lisa Ruvuna, Claire J Guo, et al.
Nature Communications|February 19, 2024
Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R StudyJohn S Kim, Yifei Sun, Pallavi Balte, et al.
NPJ Biofilms and Microbiomes|February 6, 2021
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohortKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 18, 2023
Changes in Lung Volumes with Spirometric Disease Progression in COPDMehrdad Arjomandi, Siyang Zeng, Jianhong Chen, et al.
American Journal of Respiratory and Critical Care Medicine|August 22, 2025
Associations of High Attenuation Area-related Proteomic Biomarkers with Fibrotic or Subpleural Interstitial Lung AbnormalitiesJohn S Kim, Catherine L Debban, Daniel Guzman, et al.
American Journal of Respiratory and Critical Care Medicine|October 7, 2025
Maternal Smoking and CC-16: Implications for Lung Development and COPD Across the LifespanJoselyn Rojas-Quintero, Rosa Faner, Chia-Ying Chiu, et al.
American Journal of Respiratory and Critical Care Medicine|January 23, 2024
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary DiseaseKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
Pageof 29